Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice.
Stewart CF, Leggas M, Schuetz JD, Panetta JC, Cheshire PJ, Peterson J, Daw N, Jenkins JJ 3rd, Gilbertson R, Germain GS, Harwood FC, Houghton PJ.
Stewart CF, et al. Among authors: jenkins jj 3rd.
Cancer Res. 2004 Oct 15;64(20):7491-9. doi: 10.1158/0008-5472.CAN-04-0096.
Cancer Res. 2004.
PMID: 15492275